Rainier Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Rainier Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-48,580	Closed	-$11.7M	–	205
2015 Q2	$11.7M	Buy	48,580 +5,040	+12%	+$1.34M	0.37%	119
2015 Q1	$12.3M	Sell	43,540 -200	-0.5%	-$43.3K	0.25%	141
2014 Q4	$6.82M	Buy	+43,740	New	+$8.08M	0.12%	174
2013 Q4	–	Sell	-15,610	Closed	-$1.08M	–	223
2013 Q3	$1.08M	Buy	+15,610	New	+$771K	0.01%	197

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Rainier Investment Management's ICPT Position: Q3 2015 in Review

Rainier Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2015, closing a stake of 48,580 shares — an estimated $11.7M sold.

Rainier Investment Management first reported a position in ICPT in Q3 2013 and held it in 4 quarters. The position peaked at $12.3M in Q1 2015. 173 funds tracked by Wall St. Rank hold ICPT as of Q3 2015.

Rainier Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Rainier Investment Management sold 48,580 Intercept Pharmaceuticals, Inc. shares in Q3 2015, an estimated $11.7M.
Rainier Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 4 quarters.
Rainier Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $12.3M in Q1 2015.
173 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2015.

Based on Rainier Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.